{"id":"https://openalex.org/W2013449052","doi":"https://doi.org/10.1038/sj.bjp.0705428","title":"Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists","display_name":"Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists","alternate_titles":[],"publication_year":2003,"publication_date":"2003-09-01","ids":{"openalex":"https://openalex.org/W2013449052","doi":"https://doi.org/10.1038/sj.bjp.0705428","mag":"2013449052","pmid":"https://pubmed.ncbi.nlm.nih.gov/12970098","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1574025"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0705428","doi":"https://doi.org/10.1038/sj.bjp.0705428","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705428","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705428","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2013449052"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705428","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010139280","display_name":"Elena Riboldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Riboldi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029006093","display_name":"Giada Frascaroli","orcid":"https://orcid.org/0000-0001-8186-7594","observed_orcids":["https://orcid.org/0000-0001-8186-7594"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giada Frascaroli","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088722359","display_name":"Pietro Transidico","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pietro Transidico","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021220662","display_name":"Walter Luini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Walter Luini","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070978913","display_name":"Sergio Bernasconi","orcid":"https://orcid.org/0000-0002-1788-3052","observed_orcids":["https://orcid.org/0000-0002-1788-3052"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sergio Bernasconi","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Francesca Mancini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Mancini","raw_affiliation_strings":["ACRAF, S. Palomba-Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACRAF, S. Palomba-Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074969763","display_name":"Angelo Guglielmotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angelo Guglielmotti","raw_affiliation_strings":["ACRAF, S. Palomba-Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACRAF, S. Palomba-Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058779052","display_name":"Claudio Milanese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Milanese","raw_affiliation_strings":["ACRAF, S. Palomba-Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACRAF, S. Palomba-Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052439688","display_name":"Mario Pinza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Pinza","raw_affiliation_strings":["ACRAF, S. Palomba-Pomezia, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ACRAF, S. Palomba-Pomezia, Rome, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052594030","display_name":"Silvano Sozzani","orcid":"https://orcid.org/0000-0002-3144-8743","observed_orcids":["https://orcid.org/0000-0002-3144-8743"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]},{"id":"https://openalex.org/I79940851","display_name":"University of Brescia","ror":"https://ror.org/02q2d2610","country_code":"IT","type":"education","lineage":["https://openalex.org/I79940851"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvano Sozzani","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","Unit of General Pathology and Immunology, Department of Biotechnology and Biomedical Sciences, Brescia University School of Medicine, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Unit of General Pathology and Immunology, Department of Biotechnology and Biomedical Sciences, Brescia University School of Medicine, Brescia, Italy","institution_ids":["https://openalex.org/I79940851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048654641","display_name":"Alberto Mantovani","orcid":"https://orcid.org/0000-0001-5578-236X","observed_orcids":["https://orcid.org/0000-0001-5578-236X"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Alberto Mantovani","raw_affiliation_strings":["Current address: I.R.F. \u2018Mario Negri\u2019, Via Eritrea, 62, Milan 20157, Italy","Department of General Pathology, University of Milan, Milan, Italy","Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Current address: I.R.F. \u2018Mario Negri\u2019, Via Eritrea, 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of General Pathology, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]},{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Via Eritrea 62, Milan 20157, Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5048654641"],"corresponding_institution_ids":["https://openalex.org/I189158943","https://openalex.org/I19630809"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.3327,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.58976344,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"140","issue":"2","first_page":"377","last_page":"383"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7573000192642212,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7573000192642212,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.20739999413490295,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzydamine","display_name":"benzydamine","score":1.0},{"id":"https://openalex.org/keywords/monocyte-chemotaxis","display_name":"monocyte chemotaxis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.7850000262260437},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.9739999771118164},{"id":"https://openalex.org/keywords/mek1-2","display_name":"MEK1/2","score":0.8920000195503235},{"id":"https://openalex.org/keywords/p38-mapk","display_name":"p38 MAPK","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mcp-1-ccl2","display_name":"CCL2/MCP-1","score":0.8659999966621399},{"id":"https://openalex.org/keywords/fmlp","display_name":"fMLP","score":0.9929999709129333},{"id":"https://openalex.org/keywords/c5a","display_name":"C5a","score":0.7839999794960022},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.8040000200271606},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.6959999799728394},{"id":"https://openalex.org/keywords/calcium-flux","display_name":"calcium flux","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C54166955","wikidata":"https://www.wikidata.org/wiki/Q658145","display_name":"Chemotaxis","level":3,"score":0.8883836269378662},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.5918091535568237},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5780139565467834},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.548117995262146},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.506248414516449},{"id":"https://openalex.org/C51551487","wikidata":"https://www.wikidata.org/wiki/Q2043632","display_name":"p38 mitogen-activated protein kinases","level":4,"score":0.4635187089443207},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45867854356765747},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3949511647224426},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31851330399513245},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.28106653690338135},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27680450677871704},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.19328638911247253}],"mesh":[{"descriptor_ui":"D001591","descriptor_name":"Benzydamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002630","descriptor_name":"Chemotactic Factors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002633","descriptor_name":"Chemotaxis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009240","descriptor_name":"N-Formylmethionine Leucyl-Phenylalanine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015936","descriptor_name":"Complement C5a","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018932","descriptor_name":"Chemokine CCL2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019950","descriptor_name":"Mitogen-Activated Protein Kinase 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020928","descriptor_name":"Mitogen-Activated Protein Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D048051","descriptor_name":"p38 Mitogen-Activated Protein Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048052","descriptor_name":"Mitogen-Activated Protein Kinase 3","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048369","descriptor_name":"MAP Kinase Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048370","descriptor_name":"MAP Kinase Kinase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/sj.bjp.0705428","doi":"https://doi.org/10.1038/sj.bjp.0705428","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705428","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705428","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:12970098","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12970098","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1574025","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1574025/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmh:oai:iris.unibs.it:11379/273","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/273","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.uniroma1.it:11573/1371197","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/1371197","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0705428","doi":"https://doi.org/10.1038/sj.bjp.0705428","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0705428","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0705428","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W2013449052.pdf"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W70148692","https://openalex.org/W93284168","https://openalex.org/W174240863","https://openalex.org/W205761956","https://openalex.org/W585079073","https://openalex.org/W1524916563","https://openalex.org/W1549186972","https://openalex.org/W1588772002","https://openalex.org/W1606456243","https://openalex.org/W1637979534","https://openalex.org/W1655860314","https://openalex.org/W1921708445","https://openalex.org/W1938206116","https://openalex.org/W1966931906","https://openalex.org/W1976462601","https://openalex.org/W1995441274","https://openalex.org/W2001399809","https://openalex.org/W2006780907","https://openalex.org/W2007615256","https://openalex.org/W2013023341","https://openalex.org/W2019879894","https://openalex.org/W2022453432","https://openalex.org/W2028579579","https://openalex.org/W2032731042","https://openalex.org/W2041831485","https://openalex.org/W2052638684","https://openalex.org/W2053383702","https://openalex.org/W2088894802","https://openalex.org/W2098719212","https://openalex.org/W2103685679","https://openalex.org/W2130361087","https://openalex.org/W2159543436","https://openalex.org/W2168808956","https://openalex.org/W2170727524","https://openalex.org/W2184074330","https://openalex.org/W2341881834","https://openalex.org/W2474861722","https://openalex.org/W2919572498","https://openalex.org/W4313347646","https://openalex.org/W4313377128"],"related_works":["https://openalex.org/W2092185982","https://openalex.org/W2015809158","https://openalex.org/W1481829829","https://openalex.org/W2040025197","https://openalex.org/W2095235406","https://openalex.org/W1993013149","https://openalex.org/W2506649780","https://openalex.org/W2028115805","https://openalex.org/W2022453432","https://openalex.org/W2086636757"],"abstract_inverted_index":{"1.":[0],"The":[1,61],"present":[2],"study":[3],"was":[4,63,153],"aimed":[5],"to":[6,26,41,120,151,208,212],"investigate":[7],"the":[8,28,46,51,56,80,85,134,171,195],"effect":[9,62,86],"of":[10,16,32,44,67,82,92,100,104,133,141,161,166,184,198,215],"benzydamine,":[11],"an":[12,164],"anti-inflammatory":[13,196],"drug":[14],"devoid":[15],"activity":[17,197],"on":[18,22],"arachidonic":[19],"acid":[20],"metabolism,":[21],"monocyte":[23,37,206],"chemotaxis":[24,38,94,101],"and":[25,55,70,76,95,97,106,140,217],"define":[27],"possible":[29],"biochemical":[30],"correlates":[31],"activity.":[33],"2.":[34],"Benzydamine":[35,128],"inhibited":[36,130,155],"in":[39,88,102,118,149],"response":[40,103,119,150],"three":[42],"classes":[43],"chemoattractants:":[45],"prototypic":[47],"CC-chemokine":[48],"CCL2":[49],"(MCP-1),":[50],"microbial":[52],"product":[53],"fMLP":[54,75,105],"complement":[57],"cascade":[58],"component":[59],"C5a.":[60],"dose-dependent":[64],"with":[65,163,176],"IC50's":[66],"100,":[68],"50":[69],"45":[71],"microm":[72,159,178],"for":[73],"MCP-1/CCL2,":[74],"C5a,":[77,107],"respectively.":[78],"At":[79],"dose":[81],"100":[83,158,177],"microm,":[84],"resulted":[87],"a":[89,157,181,213],"50+/-10%":[90],"inhibition":[91,183],"MCP-1/CCL2-induced":[93],"53+/-6":[96],"54+/-5%":[98],"inhibitions":[99],"respectively":[108],"(n=3).":[109],"3.":[110],"Receptor":[111],"expression":[112],"as":[113,115],"well":[114],"calcium":[116],"fluxes":[117],"chemoattractants":[121,152],"were":[122],"not":[123],"affected":[124],"by":[125,156],"benzydamine.":[126],"4.":[127],"strongly":[129],"chemoattractant-induced":[131],"activation":[132,148,186],"mitogen-activated":[135],"protein":[136],"kinase":[137,145],"(MAPK)":[138],"ERK1/2,":[139],"its":[142],"upstream":[143],"activator":[144],"MEK1/2.":[146],"ERK1/12":[147],"89-98%":[154],"concentration":[160],"benzydamine":[162,179,199],"IC50":[165],"30":[167],"microm.":[168],"5.":[169],"Under":[170],"same":[172],"experimental":[173],"conditions,":[174],"pretreatment":[175],"caused":[180],"75-89%":[182],"p38":[185,218],"(IC50":[187],"25":[188],"microm).":[189],"6.":[190],"These":[191],"results":[192],"indicate":[193],"that":[194],"is":[200],"exerted":[201],"at":[202],"multiple":[203],"levels,":[204],"including":[205],"migration":[207],"chemotactic":[209],"factors":[210],"associated":[211],"blockage":[214],"ERK":[216],"MAPK":[219],"pathways.":[220]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2013449052","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}
